Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States

Edward Burn, Anthony G. Sena, Albert Prats-Uribe, Matthew Spotnitz, Scott DuVall, Kristine E. Lynch, Michael E. Matheny, Fredrik Nyberg, Waheed-Ul-Rahman Ahmed, Osaid Alser, Heba Alghoul, Thamir Alshammari, Lin Zhang, Paula Casajust, Carlos Areia, Karishma Shah, Christian Reich, Clair Blacketer, Alan Andryc, Stephen Fortin, Karthik Natarajan, Mengchun Gong, Asieh Golozar, Daniel Morales, Peter Rijnbeek, Vignesh Subbian, Elena Roel, Martina Recalde, Jennifer C.E. Lane, David Vizcaya, Jose D. Posada, Nigam H. Shah, Jitendra Jonnagaddala, Lana Yin Hui Lai, Francesc Xavier Avilés-Jurado, George Hripcsak, Marc A. Suchard, Otavio T. Ranzani, Patrick Ryan, Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles
doi: https://doi.org/10.1101/2020.11.25.20229088
Edward Burn
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
2Centre for Statistics in Medicine, NDORMS, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony G. Sena
3Janssen Research & Development, Titusville, NJ, USA
4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Prats-Uribe
2Centre for Statistics in Medicine, NDORMS, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Spotnitz
5Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott DuVall
6Department of Veterans Affairs, Salt Lake City, UT, US
7University of Utah School of Medicine, Salt Lake City, UT, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristine E. Lynch
6Department of Veterans Affairs, Salt Lake City, UT, US
8Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Matheny
9Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA
10Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Nyberg
11School of Public Health and Community Medicine,, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Waheed-Ul-Rahman Ahmed
12Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
13College of Medicine and Health, University of Exeter, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osaid Alser
14Massachusetts General Hospital, Harvard Medical School, Boston, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heba Alghoul
15Faculty of Medicine, Islamic University of Gaza, Palestine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thamir Alshammari
16Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhang
17School of Population Medicine and Public Health, Peking Union Medical College and Chinese Academy of Medical Sciences
18School of Population and Global Health, The University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Casajust
19Real-World Evidence, Trial Form Support, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Areia
20Nuffield Department of Clinical Neurosciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karishma Shah
12Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Reich
21Real World Solutions, IQVIA, Cambridge, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clair Blacketer
3Janssen Research & Development, Titusville, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Andryc
3Janssen Research & Development, Titusville, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Fortin
3Janssen Research & Development, Titusville, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karthik Natarajan
5Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengchun Gong
22Southern Medical University, Guangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asieh Golozar
23Regeneron Pharmaceuticals, NY US
24Johns Hopkins Bloomberg School of Public Health, Baltimore, MD US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Morales
25Division of Population Health and Genomics, University of Dundee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rijnbeek
4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vignesh Subbian
26College of Engineering, The University of Arizona, Tucson, Arizona, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Roel
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Recalde
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
27Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer C.E. Lane
2Centre for Statistics in Medicine, NDORMS, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Vizcaya
28Bayer Pharmaceuticals, Sant Joan Despi, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose D. Posada
29Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigam H. Shah
29Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jitendra Jonnagaddala
30School of Public Health and Community Medicine, UNSW Sydney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lana Yin Hui Lai
31Division of Cancer Sciences, School of Medical Sciences, University of Manchester
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesc Xavier Avilés-Jurado
32Otorhinolaryngology Head-Neck Surgery Department, Hospital Clínic, IDIBAPS Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain
33Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya, 2017-SGR-01581, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Hripcsak
5Department of Biomedical Informatics, Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc A. Suchard
34Department of Biostatistic, UCLA Fielding School of Public Health, University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otavio T. Ranzani
35Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
36Pulmonary Division, Heart Institute (InCor, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Ryan
3Janssen Research & Development, Titusville, NJ, USA
37Columbia University, New York, NY, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Prieto-Alhambra
2Centre for Statistics in Medicine, NDORMS, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: daniel.prietoalhambra@ndorms.ox.ac.uk
Kristin Kostka
21Real World Solutions, IQVIA, Cambridge, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talita Duarte-Salles
1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To estimate the proportion of patients hospitalized with COVID-19 who undergo dialysis, tracheostomy, and extracorporeal membrane oxygenation (ECMO).

Design A network cohort study.

Setting Six databases from the United States containing routinely-collected patient data: HealthVerity, Premier, IQVIA Open Claims, Optum EHR, Optum SES, and VA-OMOP.

Patients Patients hospitalized with a clinical diagnosis or a positive test result for COVID-19.

Interventions Dialysis, tracheostomy, and ECMO.

Measurements and Main Results 240,392 patients hospitalized with COVID-19 were included (22,887 from HealthVerity, 139,971 from IQVIA Open Claims, 29,061 from Optum EHR, 4,336 from OPTUM SES, 36,019 from Premier, and 8,118 from VA-OMOP). Across the six databases, 9,703 (4.04% [95% CI: 3.96% to 4.11%]) patients received dialysis, 1,681 (0.70% [0.67% to 0.73%]) had a tracheostomy, and 398 (0.17% [95% CI: 0.15% to 0.18%]) patients underwent ECMO over the 30 days following hospitalization. Use of ECMO was generally concentrated among patients who were younger, male, and with fewer comorbidities except for obesity. Tracheostomy was used for a similar proportion of patients regardless of age, sex, or comorbidity. While dialysis was used for a similar proportion among younger and older patients, it was more frequent among male patients and among those with chronic kidney disease.

Conclusion Use of dialysis among those hospitalized with COVID-19 is high at around 4%. Although less than one percent of patients undergo tracheostomy and ECMO, the absolute numbers of patients who have undergone these interventions is substantial and can be expected to continue grow given the continuing spread of the COVID-19.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form, with the following declarations made: AS reports personal fees from Janssen Research & Development, during the conduct of the study; personal fees from Janssen Research & Development, outside the submitted work. AS is a full time employee of Janssen and shareholder of Johnson & Johnson. SDV reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Biomedical Research outside the submitted work. MEM has nothing to disclose. CR is an employee of IQVIA. CB reports other from Janssen, Research and Development, outside the submitted work; and full time employee of Janssen R&D and Johnson & Johnson shareholder. AA reports other from Janssen, Research and Development, outside the submitted work; and full time employee of Janssen R&D and Johnson & Johnson shareholder. SF reports other from Janssen, outside the submitted work. AG reports personal fees from Regeneron Pharmaceuticals, outside the submitted work. She is a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. DM is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports grants from Chief Scientist Office (CSO), grants from Health Data Research UK (HDR-UK), grants from Tenovus, grants from National Institute of Health Research (NIHR), outside the submitted work. PR reports grants from Innovative Medicines Initiative, grants from Janssen Research and Development, during the conduct of the study. VS reports grants from National Science Foundation, grants from State of Arizona; Arizona Board of Regents, grants from Agency for Healthcare Research and Quality, outside the submitted work. DV reports personal fees from Bayer, outside the submitted work; and he is a full-time employee at a pharmaceutical company. GH reports grants from US NIH National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work. MAS reports grants from US National Science Foundation, grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, during the conduct of the study .PR reports and is employee of Janssen Research and Development and shareholder of Johnson & Johnson. DPA reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA's department and open for external participants. KK reports she is an employee of IQVIA. All other authors declare no competing interests.

Funding Statement

This project has received support from the European Health Data and Evidence Network (EHDEN) project. EHDEN has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union s Horizon 2020 research and innovation programme and EFPIA. This research received partial support from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), US National Institutes of Health, US Department of Veterans Affairs, Janssen Research & Development, and IQVIA. This work was supported using resources and facilities of the Department of Veterans Affairs (VA) Informatics and Computing Infrastructure (VINCI), VA HSR RES 13-457. The University of Oxford received funding related to this work from the Bill & Melinda Gates Foundation (Investment ID INV-016201 and INV-019257). Personal funding included: AP-U is supported by Fundacion Alfonso Martin Escudero and the Medical Research Council (grant numbers MR/K501256/1, MR/N013468/1), WURA reports funding from the NIHR Oxford Biomedical Research Centre (BRC), Aziz Foundation, Wolfson Foundation, and the Royal College Surgeons of England, JCEL is supported by Versus Arthritis Clinical Research Fellowship (21605) and the Medical Research Council (MR/K501256/1), GH is supported by US NIH National Library of Medicine grant R01 LM006910. OTR is funded by a Sara Borrell grant from the Instituto de Salud Carlos III (CD19/00110). DPA is supported by a NIHR Senior Research Fellowship (SRF-2018-11-ST2-004).No funders had a direct role in this study. The views and opinions expressed are those of the authors and do not necessarily reflect those of the Clinician Scientist Award programme, NIHR, department of Veterans Affairs or the United States Government, NHS, or the Department of Health, England.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the data partners received Institutional Review Board (IRB) approval or exemption. The use of VA data was reviewed by the Department of Veterans Affairs Central Institutional Review Board (IRB) and was determined to meet the criteria for exemption under Exemption Category 4(3) and approved the request for Waiver of HIPAA Authorization. The research was approved by the Columbia University Institutional Review Board as an OHDSI network study. The IRB number for use of HIRA data was AJIB-MED-EXP-20-065. SIDIAP analysis was approved by the Clinical Research Ethics Committee of the IDIAPJGol (project code: 20/070-PCV). Other databases used (IQVIA Open Claims and Optum EHR) are commercially available, syndicated data assets that are licensed by contributing authors for observational research. These assets are de-identified commercially available data products that could be purchased and licensed by any researcher. The collection and de-identification of these data assets is a process that is commercial intellectual property and not privileged to the data licensees and the co-authors on this study. Licensees of these data have signed Data Use Agreements with the data vendors which detail the usage protocols for running retrospective research on these databases. All analyses performed in this study were in accordance with Data Use Agreement terms as specified by the data owners. As these data are deemed commercial assets, there is no Institutional Review Board applicable to the usage and dissemination of these result sets or required registration of the protocol with additional ethics oversight. Compliance with Data Use Agreement terms, which stipulate how these data can be used and for what purpose, is sufficient for these commercial entities. Further inquiry related to the governance oversight of these assets can be made with the respective commercial entities: IQVIA (iqvia.com) and Optum (optum.com). At no point in the course of this study were the authors of this study exposed to identified patient-level data. All result sets represent aggregate, de-identified data that are represented at a minimum cell size of >5 to reduce potential for re-identification.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Open Science is a guiding principle within OHDSI. As such, we provide unfettered access to all open-source analysis tools employed in this study via https://github.com/OHDSI/, as well as all data and results artefacts that do not include patient-level health information via https://data.ohdsi.org/Covid19CharacterizationCharybdis/. Data partners contributing to this study remain custodians of their individual patient-level health information and hold either IRB exemption or approval for participation.”

https://data.ohdsi.org/Covid19CharacterizationCharybdis/

https://github.com/OHDSI/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States
Edward Burn, Anthony G. Sena, Albert Prats-Uribe, Matthew Spotnitz, Scott DuVall, Kristine E. Lynch, Michael E. Matheny, Fredrik Nyberg, Waheed-Ul-Rahman Ahmed, Osaid Alser, Heba Alghoul, Thamir Alshammari, Lin Zhang, Paula Casajust, Carlos Areia, Karishma Shah, Christian Reich, Clair Blacketer, Alan Andryc, Stephen Fortin, Karthik Natarajan, Mengchun Gong, Asieh Golozar, Daniel Morales, Peter Rijnbeek, Vignesh Subbian, Elena Roel, Martina Recalde, Jennifer C.E. Lane, David Vizcaya, Jose D. Posada, Nigam H. Shah, Jitendra Jonnagaddala, Lana Yin Hui Lai, Francesc Xavier Avilés-Jurado, George Hripcsak, Marc A. Suchard, Otavio T. Ranzani, Patrick Ryan, Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles
medRxiv 2020.11.25.20229088; doi: https://doi.org/10.1101/2020.11.25.20229088
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States
Edward Burn, Anthony G. Sena, Albert Prats-Uribe, Matthew Spotnitz, Scott DuVall, Kristine E. Lynch, Michael E. Matheny, Fredrik Nyberg, Waheed-Ul-Rahman Ahmed, Osaid Alser, Heba Alghoul, Thamir Alshammari, Lin Zhang, Paula Casajust, Carlos Areia, Karishma Shah, Christian Reich, Clair Blacketer, Alan Andryc, Stephen Fortin, Karthik Natarajan, Mengchun Gong, Asieh Golozar, Daniel Morales, Peter Rijnbeek, Vignesh Subbian, Elena Roel, Martina Recalde, Jennifer C.E. Lane, David Vizcaya, Jose D. Posada, Nigam H. Shah, Jitendra Jonnagaddala, Lana Yin Hui Lai, Francesc Xavier Avilés-Jurado, George Hripcsak, Marc A. Suchard, Otavio T. Ranzani, Patrick Ryan, Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles
medRxiv 2020.11.25.20229088; doi: https://doi.org/10.1101/2020.11.25.20229088

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)